EF Hutton Initiates Coverage On Humacyte With Buy Rating, Announces Price Target of $25
EF Hutton Initiates Coverage On Humacyte With Buy Rating, Announces Price Target of $25
EF Hutton發起買入評級對Humacyte進行覆蓋，宣佈目標價爲$25
EF Hutton analyst Jason Kolbert initiates coverage on Humacyte (NASDAQ:HUMA) with a Buy rating and announces Price Target of $25.
EF Hutton分析師傑森·科爾伯特以買入評級啓動了對Humacyte（納斯達克股票代碼：HUMA）的報道，並宣佈目標股價爲25美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。